Knowledge levels of oncology nurses regarding evidence-based practices in the assessment and management of chemotherapy-induced peripheral neuropathy
Authors:
Open Access
- 27 August 2024
- journal article
- research article
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 11 (10) , 100581
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic AvenuesNeurotherapeutics, 2021
- Chemotherapy-induced peripheral neuropathy and rehabilitation: A reviewSeminars in Oncology, 2021
- Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists’ professional practicesSupportive Care in Cancer, 2021
- Peripheral NeuropathyMedical Clinics of North America, 2019
- Chemotherapy‐induced peripheral neuropathy: A current reviewAnnals of Neurology, 2017
- Examining the Impact of a Web-Based Intervention to Promote Patient Activation in Chemotherapy-Induced Peripheral Neuropathy Assessment and ManagementJournal of Cancer Education, 2017
- National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessonsSupportive Care in Cancer, 2015
- Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registryGynecologic Oncology, 2014
- Preliminary Assessment of a Neuropathic Pain Treatment and Referral Algorithm for Patients With CancerJournal of Pain and Symptom Management, 2011
- The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CASupportive Care in Cancer, 2011